EAM
AMPE

Evanson Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Evanson Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-55
Closed -$48K – 216
2015
Q3 		$48K Hold
55
– – 0.02% 198
2015
Q2 		$39K Hold
55
– – 0.01% 212
2015
Q1 		$124K Hold
55
– – 0.04% 187
2014
Q4 		$57K Buy
55
+7
+15% +$7.48K 0.02% 186
2014
Q3 		$50K Buy
48
+11
+30% +$18.5K 0.02% 183
2014
Q2 		$94K Hold
37
– – 0.04% 187
2014
Q1 		$71K Hold
37
– – 0.03% 174
2013
Q4 		$80K Buy
+37
New +$87.5K 0.04% 167

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CP
Camelot Portfolios Maumee, Ohio $143M AUM 14.82% 1-Year Est. Return

Evanson Asset Management's AMPE Position: Q4 2015 in Review

Evanson Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2015, closing a stake of 55 shares — an estimated $48K sold.

Evanson Asset Management first reported a position in AMPE in Q4 2013 and held it in 8 quarters. The position peaked at $124K in Q1 2015. 57 funds tracked by Wall St. Rank hold AMPE as of Q4 2015.

  • Evanson Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2015 after selling out during the quarter.
  • Evanson Asset Management sold 55 Ampio Pharmaceuticals Inc. shares in Q4 2015, an estimated $48K.
  • Evanson Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 8 quarters.
  • Evanson Asset Management's Ampio Pharmaceuticals Inc. position peaked at $124K in Q1 2015.
  • 57 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2015.

Based on Evanson Asset Management's 13F filing for Q4 2015, filed 28 Jan 2016.